Expression of Human CEACAM Receptors Promotes Inflammation and Organ Damage During Systemic Candida albicans

Esther Klaile1,2, Mario Marco Müller2,3, Johannes Sonnberger2,4

  • 1Center for Clinical Studies, Jena University Hospital, 07747 Jena, Germany.

Cells
|April 27, 2026
PubMed

Insights

Transgenic mice expressing human carcinoembryonic antigen-related cell adhesion molecule 3, 5, and 6 (CEACAM3/5/6) showed reduced survival during Candida albicans infection due to heightened inflammation.

Area of Science:

  • Immunology
  • Mycology
  • Cell Biology

Background:

  • Invasive candidiasis is a severe fungal infection with high mortality.
  • Carcinoembryonic antigen-related cell adhesion molecule (CEACAM) receptors regulate innate immune responses.
  • Human CEACAM3, CEACAM5, and CEACAM6 recognize Candida albicans.

Purpose of the Study:

  • To investigate the role of CEACAM receptors in a murine model of invasive candidiasis.
  • To determine the impact of CEACAM expression on immune response and survival during Candida albicans infection.

Main Methods:

  • Utilized transgenic CEABAC10 mice expressing human CEACAM3, CEACAM5, and CEACAM6.
  • Inoculated mice with Candida albicans to establish a murine infection model.
  • Analyzed survival rates, cytokine levels, acute phase response, and inflammatory markers in livers and kidneys.

Main Results:

  • CEABAC10 mice exhibited significantly shortened survival compared to wild-type littermates.
  • CEABAC10 mice developed an early cytokine storm, exacerbated acute phase response, and heightened systemic inflammation.
  • Intensified necrotizing inflammation and increased neutrophil/macrophage infiltration were observed in CEABAC10 mouse livers and kidneys.
  • CEACAM6 expression on monocytes was identified as a key factor in elevated cytokine levels and exacerbated inflammation.

Conclusions:

  • CEACAM receptor expression, particularly CEACAM6 on monocytes, exacerbates the immune response to Candida albicans infection.
  • This heightened inflammatory response leads to decreased survival in CEABAC10 mice.
  • CEACAMs represent potential therapeutic targets for managing invasive candidiasis.